Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit
ESC Congress 2025

ESC Congress 2025

ESC Congress 2025

ESC Congress 2025

Influenza Poster per i pazienti

Influenza Poster per i pazienti

Influenza Broschura per i pazienti

Influenza Broschura per i pazienti

Malattie da viaggio Brochure

Malattie da viaggio Brochure

Sverige satsar på att skydda spädbarn mot RSV med start 10 september – Beyfortus (nirsevimab) finns nu tillgängligt

RSV-prevention med Beyfortus (nirsevimab) – tillgänglig för nyfödda från 10 september

Beyfortus® är den första och enda RSV-immuniseringen designad för alla spädbarn, för skydd mot RSV-sjukdom i de nedre luftvägarna (LRTD).1

Thông tin kê toa vắc-xin TETRAXIM

Thông tin kê toa vắc-xin TETRAXIM

TMS Airway ADVENT: Advancing Type 2 Airway Disease Management

TMS Airway ADVENT: Advancing Type 2 Airway Disease Management

TMS Airway ADVENT: Advancing Type 2 Airway Disease Management

TMS Airway ADVENT: Advancing Type 2 Airway Disease Management

TMS Airway ADVENT: Advancing Type 2 Airway Disease Management

TMS Airway ADVENT: Advancing Type 2 Airway Disease Management

Pooled analysis: Interventional and observational studies

Pooled analysis: Interventional and observational studies

A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy.1

EFLUELDA - Seasonal high dose flu vaccine

EFLUELDA - Seasonal high dose flu vaccine